Vincent Wong
Direktor/Vorstandsmitglied bei BIONANO GENOMICS, INC.
Profil
Mr. Vincent J.
Wong is an Independent Director at Bionano Genomics, Inc. He is on the Board of Directors at Bionano Genomics, Inc. Mr. Wong was previously employed as a Chief Commercial Officer by Geneoscopy, Inc. He received his undergraduate degree from the University of Notre Dame, a graduate degree from Indiana University Maurer School of Law and an MBA from Kellogg School of Management.
Aktive Positionen von Vincent Wong
Unternehmen | Position | Beginn |
---|---|---|
BIONANO GENOMICS, INC. | Direktor/Vorstandsmitglied | 22.12.2021 |
Ehemalige bekannte Positionen von Vincent Wong
Unternehmen | Position | Ende |
---|---|---|
Geneoscopy, Inc.
Geneoscopy, Inc. Miscellaneous Commercial ServicesCommercial Services Geneoscopy LLC develops diagnostics It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. The firm provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. The company was founded by Andrew Barnell, Erica Barnell and Yiming Kang in 2015 and is headquartered in Saint Louis, MO. | Corporate Officer/Principal | 01.01.2024 |
Ausbildung von Vincent Wong
University of Notre Dame | Undergraduate Degree |
Indiana University Maurer School of Law | Graduate Degree |
Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIONANO GENOMICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Geneoscopy, Inc.
Geneoscopy, Inc. Miscellaneous Commercial ServicesCommercial Services Geneoscopy LLC develops diagnostics It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. The firm provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. The company was founded by Andrew Barnell, Erica Barnell and Yiming Kang in 2015 and is headquartered in Saint Louis, MO. | Commercial Services |